Therapeutic Outcomes and Risk Factors for Complications of Endoscopic Papillectomy: A Retrospective Analysis of a Single-Center Study

Overview

Journal Ther Clin Risk Manag

Publisher Dove Medical Press

Date 2021 Jun 7

PMID 34093018

Citations 2

Authors

Lei Jiang

Ningli Chai

Mingyan Li

Enqiang Linghu

Affiliations

Soon will be listed here.

Abstract

Purpose: Endoscopic papillectomy (EP) has been accepted as a viable alternative therapy to surgery in benign duodenal papillary lesions. However, postoperative complications limit its widespread clinical application. This study aimed to evaluate the overall safety of the EP procedure and identify significant risk factors of post-EP complications.

Patients And Methods: We retrospectively collected 76 patients who had undergone EP in Chinese PLA General Hospital from 2016 to 2019 and graded their postoperative complications. We assessed twelve patient-, disease- or procedure-related variables to identify risk factors related to the occurrence of post-EP complications using both univariate and multivariate analyses.

Results: Among the 76 patients included in this study, the incidence of entire post-EP complications was 36.8%, most of which were in a mild form. In both univariate and multivariate analyses, the pathologic tumor types, especially high-grade intraepithelial neoplasia (HIN), and the placement of stents were significantly associated with the occurrence of post-EP complications. Patients with HIN tumors were more likely to have post-EP pancreatitis, bleeding, and overall complications (odds ratio (OR) 11.66, 95% confidence interval (CI) 2.91-62.5, = 0.001; OR 6.52, 95% CI 1.45-46.77, = 0.027; OR 9.81, 95% CI 2.75-44.04, = 0.001, respectively). Pancreatic stent placement may contribute to the occurrence of post-EP pancreatitis (OR 7.61, 95% CI 1.37-64.53, = 0.033). While biliary stent placement was found negatively related to the occurrence of post-EP bleeding and overall complications (OR 0.02, 95% CI 0-0.37, = 0.016; OR 0.11, 95% CI 0.01-0.99, = 0.05, respectively).

Conclusion: EP is a safe procedure for papillary lesion treatment with a low rate and generally mild postoperative complications. Two factors are significantly associated with the occurrence of complications. The selection of eligible patients and suitable procedures is important to reduce the complication rate and severity.

Citing Articles

Factors associated with delayed bleeding following ampullectomy: A retrospective cohort study.

Pawlak K, Khalaf K, Gupta S, Tham D, Chon J, Mokhtar A DEN Open. 2025; 5(1):e70078.

PMID: 39959850 PMC: 11827579. DOI: 10.1002/deo2.70078.

Impact of pancreatic and biliary stent on post-endoscopic papillectomy complications: A single-center retrospective study.

Ru N, Chai N, Zhang B, Li L, Bi Y, Linghu E Chin Med J (Engl). 2024; 137(17):2111-2118.

PMID: 38809090 PMC: 11374298. DOI: 10.1097/CM9.0000000000002893.

Risk Factors of Non-en Bloc Resection and Non-R0 Resection During Endoscopic Resection in the Treatment of Superficial Duodenal Epithelial Lesions.

Fu S, Gong J, Zhou M, Wang Y, Liu D, Tan Y Front Oncol. 2022; 12:881815.

PMID: 35669421 PMC: 9163665. DOI: 10.3389/fonc.2022.881815.

References

Adler D, Qureshi W, Davila R, Gan S, Lichtenstein D, Rajan E . The role of endoscopy in ampullary and duodenal adenomas. Gastrointest Endosc. 2006; 64(6):849-54. DOI: 10.1016/j.gie.2006.08.044. View

Attaallah W, Gunal O, Mokhtare S, Ozmen T, Cingi A . Endoscopic snare excision of adenoma of the papilla of Vater without prophylactic pancreatic-duct stent. JOP. 2014; 15(6):587-90. DOI: 10.6092/1590-8577/2639. View

Silvis S . Endoscopic snare papillectomy. Gastrointest Endosc. 1993; 39(2):205-7. DOI: 10.1016/s0016-5107(93)70074-7. View

Kim M, Lee S, Seo D, Won S, Lee S, Min Y . Tumors of the major duodenal papilla. Gastrointest Endosc. 2001; 54(5):609-20. DOI: 10.1067/mge.2001.119254. View

Stolte M, Pscherer C . Adenoma-carcinoma sequence in the papilla of Vater. Scand J Gastroenterol. 1996; 31(4):376-82. DOI: 10.3109/00365529609006414. View

Will U, Muller A, Fueldner F, Wanzar I, Meyer F . Endoscopic papillectomy: data of a prospective observational study. World J Gastroenterol. 2013; 19(27):4316-24. PMC: 3718899. DOI: 10.3748/wjg.v19.i27.4316. View

Ito K, Fujita N, Noda Y, Kobayashi G, Obana T, Horaguchi J . Impact of technical modification of endoscopic papillectomy for ampullary neoplasm on the occurrence of complications. Dig Endosc. 2012; 24(1):30-5. DOI: 10.1111/j.1443-1661.2011.01161.x. View

Katsinelos P, Paroutoglou G, Kountouras J, Beltsis A, Papaziogas B, Mimidis K . Safety and long-term follow-up of endoscopic snare excision of ampullary adenomas. Surg Endosc. 2006; 20(4):608-13. DOI: 10.1007/s00464-004-2278-0. View

Jung M, Cho C, Park S, Jeon S, Tak W, Kweon Y . Endoscopic resection of ampullary neoplasms: a single-center experience. Surg Endosc. 2009; 23(11):2568-74. DOI: 10.1007/s00464-009-0464-9. View

10.

Soma H, Miyata N, Hozawa S, Higuchi H, Yamagishi Y, Nakamura Y . Ampullary Adenoma Treated by Endoscopic Double-Snare Retracting Papillectomy. Gut Liver. 2015; 9(5):689-92. PMC: 4562789. DOI: 10.5009/gnl14206. View

11.

Taglieri E, Micelli-Neto O, Bonin E, Goldman S, Kemp R, Dos Santos J . Analysis of risk factors associated with acute pancreatitis after endoscopic papillectomy. Sci Rep. 2020; 10(1):4132. PMC: 7057991. DOI: 10.1038/s41598-020-60941-3. View

12.

Lee R, Huelsen A, Gupta S, Hourigan L . Endoscopic ampullectomy for non-invasive ampullary lesions: a single-center 10-year retrospective cohort study. Surg Endosc. 2020; 35(2):684-692. DOI: 10.1007/s00464-020-07433-7. View

13.

Harewood G, Pochron N, Gostout C . Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla. Gastrointest Endosc. 2005; 62(3):367-70. DOI: 10.1016/j.gie.2005.04.020. View

14.

Catalano M, Linder J, Chak A, Sivak Jr M, Raijman I, Geenen J . Endoscopic management of adenoma of the major duodenal papilla. Gastrointest Endosc. 2004; 59(2):225-32. DOI: 10.1016/s0016-5107(03)02366-6. View

15.

Sahar N, Krishnamoorthi R, Kozarek R, Gluck M, Larsen M, Ross A . Long-Term Outcomes of Endoscopic Papillectomy for Ampullary Adenomas. Dig Dis Sci. 2019; 65(1):260-268. DOI: 10.1007/s10620-019-05812-2. View

16.

Irani S, Arai A, Ayub K, Biehl T, Brandabur J, Dorer R . Papillectomy for ampullary neoplasm: results of a single referral center over a 10-year period. Gastrointest Endosc. 2009; 70(5):923-32. DOI: 10.1016/j.gie.2009.04.015. View

17.

Chung K, Lee S, Choi J, Kang J, Paik W, Ahn D . Effect of submucosal injection in endoscopic papillectomy of ampullary tumor: Propensity-score matching analysis. United European Gastroenterol J. 2018; 6(4):576-585. PMC: 5987269. DOI: 10.1177/2050640617745459. View

18.

Ismail S, Marianne U, Heikki J, Jorma H, Leena K . Endoscopic papillectomy, single-centre experience. Surg Endosc. 2014; 28(11):3234-9. DOI: 10.1007/s00464-014-3596-5. View

19.

Igarashi Y, Okano N, Ito K, Mimura T, Nakano S . Endoscopic snare excision of a major duodenal papillary tumor. Dig Surg. 2010; 27(2):119-22. DOI: 10.1159/000286715. View

20.

Ghidirim G, Misin I, Istrate V, Cazacu S . Endoscopic papillectomy into the treatment of neoplastic lesions of vater papilla. Curr Health Sci J. 2014; 35(2):92-7. PMC: 3945241. View